首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal GPS1 Antibody

  • 中文名: GPS1抗体
  • 别    名: COP9 signalosome complex subunit 1, SGN1, Signalosome subunit 1, G protein pathway suppressor 1, GPS-1, JAB1-containing signalosome subunit 1, Protein MFH, GPS1, COPS1, CSN1
货号: IPDX31135
Price: ¥1180
数量:
大包装询价

验证与应用

应用及物种
WB 1/1000 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 咨询技术 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesCOP9 signalosome complex subunit 1, SGN1, Signalosome subunit 1, G protein pathway suppressor 1, GPS-1, JAB1-containing signalosome subunit 1, Protein MFH, GPS1, COPS1, CSN1
Entrez GeneID2873
WB Predicted band size55.5kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityMouse
ImmunogenThis GPS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 141-170 amino acids from the Central region of human GPS1.
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

nan

背景信息

GPS1 (G Protein Pathway Suppressor 1), also known as COPS1 or CSN1. is a critical subunit of the COP9 signalosome (CSN), a conserved protein complex involved in regulating ubiquitin-dependent proteolysis. The CSN complex, composed of eight subunits (CSN1–CSN8), plays a central role in modulating cullin-RING ubiquitin ligases (CRLs), which mediate protein degradation via the ubiquitin-proteasome system. GPS1/CSN1 contributes to the structural integrity of the CSN complex and participates in deneddylation, a process that removes NEDD8 post-translational modifications from cullins to regulate CRL activity. This dynamic control impacts diverse cellular processes, including cell cycle progression, DNA repair, and stress responses.

GPS1 is implicated in key signaling pathways, such as NF-κB and JNK, through its interaction with CRLs. Dysregulation of GPS1 expression or function has been linked to pathological conditions, including cancer, neurodegenerative disorders, and immune dysregulation. For instance, reduced GPS1 levels correlate with tumor progression due to altered protein stability of oncogenes or tumor suppressors. In neurodegenerative contexts, defective CSN activity may disrupt protein homeostasis, contributing to aggregation-prone environments.

Antibodies targeting GPS1 are essential tools for studying its expression, localization, and molecular interactions. They are widely used in techniques like Western blotting, immunoprecipitation, and immunofluorescence to explore GPS1's role in cellular pathways and disease mechanisms. These antibodies also aid in evaluating therapeutic strategies aimed at modulating ubiquitin-proteasome activity or CSN-associated pathways.

客户数据及评论

折叠内容

大包装询价

×